HOME › Press Releases › Nerve Repair and Regeneration Market worth 10,398.79 Million USD by 2020
Nerve Repair and Regeneration Market worth 10,398.79 Million USD by 2020
The report “Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Devices) - Global Forecast to 2020” report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global nerve repair and regeneration market along with the estimates and forecasts of the revenue and market share analysis.
Browse 72 tables and 66 figures spread through 150 pages and in-depth TOC on "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Devices) - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
The global nerve repair and regeneration market is valued at USD 5,945.69 Million in 2015. This market is expected to grow at a CAGR of 11.83% to reach USD 10,398.79 Million in 2020.
The rapidly increasing incidence of peripheral nerve injuries and neurological disorders is a major growth driver for this market. Furthermore, technological advancement in nerve repair and favorable reimbursement policies will be an important driver for the nerve repair and regeneration market.
The nerve repair and regeneration market is segmented on the basis of application, product, and geography. The application segments included in this report are direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and neurostimulation and neuromodulation. The direct nerve repair/neurorrhaphy surgery segment is further categorized into epineural repair, perineural repair, and group fascicular repair. The nerve grafting surgery segment is further categorized into autografts, allografts, and xenografts. The neurostimulation and neuromodulation surgery segment is further categorized into external and internal neurostimulation surgeries.
The product segments included in this report are biomaterials and neurostimulation & neuromodulation devices. The subsegments of the biomaterials product segment are nerve conduits, nerve protectors, nerve wraps, and nerve connectors. The neurostimulation and neuromodulation devices product segment is further categorized into internal and external neurostimulation and neuromodulation devices. The subsegments of the internal neurostimulation and neuromodulation segment are spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation. The subsegments of the external neurostimulation and neuromodulation product segment are transcutaneous electrical nerve stimulation, and transcranial magnetic stimulation.
The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America is expected to account for the largest share of the global nerve repair and regeneration market in 2015. The large share of this region can be attributed to the provisions of the Patient Protection and Affordable Care Act (PPACA), which has increased the number of individuals with insurance cover in the U.S. The PPACA is expected to reduce the number of nonelderly people without health insurance coverage by 14 million in 2014 and by about 30 million by 2022. This will result in increased access to healthcare, which in turn will aid the growth of the North American market. On the other hand, the Asian market is expected to grow rapidly at a higher CAGR in the forecast period owing to the rapid rise in the aging population, increasing healthcare expenditure, and the large untapped potential of Asia’s markets.
The major companies in the nerve repair and regeneration market are AxoGen Inc. (U.S.), Baxter International (U.S.), Boston Scientific Incorporation (U.S.), Cyberonics Inc. (U.S.), Integra Lifesciences Corporation (U.S.), Medtronic plc (U.S.), Orthomed S.A.S. (France), Polyganics B.V. (Netherland), St. Jude Medical (U.S.), and Stryker Corporation (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India